Clinical trial
Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation (CASTLE-HTx)
NCT04649801 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation (CASTLE-HTx)
- Lead sponsor
- Heart and Diabetes Center North-Rhine Westfalia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- May 15, 2023
- Enrollment
- 194 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.